CNBC's Jim Cramer on Thursday named sectors that have seen major gains recently and warned investors not to buy them while they're hot.
a jump of 11.8% and ahead of an average analyst estimate of 1.55 billion euros in a consensus posted on the company’s website ...
The German pharma and technology company said in a statement that earnings before interest, taxes, depreciation and ...
The collaboration with Merck KGaA, Darmstadt, Germany focuses on discovering ... A live webcast of the presentation will be ...
The Children’s Inn at the National Institutes of Health is breaking ground on a project that will allow the nonprofit to ...
Phase III MANEUVER study met primary endpoint, with an objective response rate at week 25 of 54.0% for pimicotinib versus 3.2% for placebo (p<0.0001) Statistically significant and clinically ...